Volume 47, Issue 2

Search all Cellular Oncology articles

April 2024

Filter by

Volume:

Sort by

Date published:

New to old Old to new

21 articles in this issue

From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment
Zeyu Zhang
Jinxin Tao
Taiping Zhang
Review 19 September 2023 Pages: 361 - 381
Part of 1 collection:

Cancer-Associated Fibroblasts
Fibroblast subtypes in pancreatic cancer and pancreatitis: from mechanisms to therapeutic strategies
Huizhen Huang
Wanyi Lu
Li Wen
Review 18 September 2023 Pages: 383 - 396
Part of 1 collection:

Cancer-Associated Fibroblasts
The microbiota and renal cell carcinoma
Ke Wu
Yaorong Li
Junhua Zheng
Review 25 October 2023 Pages: 397 - 413
Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy
Liang Li
Si-Rui Ma
Zi-Li Yu
Review 30 September 2023 Pages: 415 - 428
Part of 1 collection:

Tumor Immunology
Redox signaling-mediated tumor extracellular matrix remodeling: pleiotropic regulatory mechanisms
Guowen Liu
Bowen Li
Canhua Huang
Review 04 October 2023 Pages: 429 - 445
Immune characteristics associated with lymph node metastasis in early-stage NSCLC
Ziyu Zhang
Li Li
Min Li
Research 20 September 2023 Pages: 447 - 461
Part of 1 collection:

Tumor Immunology
Notum enhances gastric cancer stem-like cell properties through upregulation of Sox2 by PI3K/AKT signaling pathway
Yi Liu
Hui Chen
Lisong Shen
Research Open access 26 September 2023 Pages: 463 - 480
Identifying the effectiveness of 3D culture systems to recapitulate breast tumor tissue in situ
Katarzyna A. Ludwik
Frances R. Greathouse
Deborah A. Lannigan
Research Open access 30 September 2023 Pages: 481 - 496
Neuropilin-2 acts a critical determinant for epithelial-to-mesenchymal transition and aggressive behaviors of human head and neck cancer
Min-Hye Ahn
Ji-Hoon Kim
Sung-Dae Cho
Research 03 October 2023 Pages: 497 - 511
SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma
Zengbin Wang
Banglun Pan
Nanhong Tang
Research 06 December 2023 Pages: 513 - 532
Part of 1 collection:

Tumor Immunology
Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancer
Ellen Finnegan
Wei Ding
Sudipto Das
Research Open access 07 November 2023 Pages: 533 - 553
Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma
Long Shu
Jun Tang
Yongguang Tao
Research 09 October 2023 Pages: 555 - 571
Part of 1 collection:

Tumor Immunology
High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer
Jingjing Guo
Baijie Tang
Xue Xiao
Research Open access 17 October 2023 Pages: 573 - 585
Part of 1 collection:

Tumor Immunology
Identifying cancer subtypes based on embryonic and hematopoietic stem cell signatures in pan-cancer
Jiali Lei
Jiangti Luo
Xiaosheng Wang
Research 12 October 2023 Pages: 587 - 605
Inhibition of thioredoxin-1 enhances the toxicity of glycolysis inhibitor 2-deoxyglucose by downregulating SLC1A5 expression in colorectal cancer cells
Tianbin Tang
Daoquan Fang
Xuecheng Sun
Research 23 October 2023 Pages: 607 - 621
FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC
Jie Liu
Yeling Ouyang
Jing Liao
Research 19 October 2023 Pages: 623 - 638
Part of 1 collection:

Tumor Immunology
Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis
Hong-Juan You
Li-Hong Ma
Ren-Xian Tang
Research 17 October 2023 Pages: 639 - 655
Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways
Mei Meng
Yan Guo
Quansheng Zhou
Research Open access 04 November 2023 Pages: 657 - 676
Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach
Jingtao Wei
Ke Ji
Zhaode Bu
Research 09 November 2023 Pages: 677 - 693
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer
Cristina Di Giorgio
Rachele Bellini
Stefano Fiorucci
Research Open access 09 November 2023 Pages: 695 - 710
Feature-weight based measurement of cancerous transcriptome using cohort-wide and sample-specific information
Qilu Wang
Jiaoyang Jessie Song
Feng Zhang
Brief Report 09 October 2023 Pages: 711 - 715

Volume 47, Issue 2

From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment

Fibroblast subtypes in pancreatic cancer and pancreatitis: from mechanisms to therapeutic strategies

The microbiota and renal cell carcinoma

Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy

Redox signaling-mediated tumor extracellular matrix remodeling: pleiotropic regulatory mechanisms

Immune characteristics associated with lymph node metastasis in early-stage NSCLC

Notum enhances gastric cancer stem-like cell properties through upregulation of Sox2 by PI3K/AKT signaling pathway

Identifying the effectiveness of 3D culture systems to recapitulate breast tumor tissue in situ

Neuropilin-2 acts a critical determinant for epithelial-to-mesenchymal transition and aggressive behaviors of human head and neck cancer

SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma

Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancer

Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma

High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer

Identifying cancer subtypes based on embryonic and hematopoietic stem cell signatures in pan-cancer

Inhibition of thioredoxin-1 enhances the toxicity of glycolysis inhibitor 2-deoxyglucose by downregulating SLC1A5 expression in colorectal cancer cells

FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC

Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis

Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways

Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach

The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer

Feature-weight based measurement of cancerous transcriptome using cohort-wide and sample-specific information

Navigation